Hsbc Holdings PLC Amicus Therapeutics, Inc. Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 22,956 shares of FOLD stock, worth $231,626. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,956

Previous 31,273 26.59%

Holding current value

$231,626

Previous $310,000 20.97%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$9.55 - $12.09 $79,427 - $100,552	-8,317 Reduced 26.59%	22,956 $245,000
Q2 2024 Aug 12, 2024	BUY	$9.04 - $11.75 $7,313 - $9,505	809 Added 2.66%	31,273 $310,000
Q1 2024 May 15, 2024	BUY	$11.43 - $14.24 $348,203 - $433,807	30,464 New	30,464 $358,000
Q3 2021 Nov 12, 2021	SELL	$8.74 - $11.84 $90,371 - $122,425	-10,340 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$8.71 - $10.72 $90,061 - $110,844	10,340 New	10,340 $99,000
Q1 2021 May 14, 2021	SELL	$9.2 - $23.86 $306,010 - $793,631	-33,262 Closed	0 $0
Q4 2020 Feb 25, 2021	BUY	$13.47 - $24.89 $15,638 - $28,897	1,161 Added 3.62%	33,262 $768,000
Q4 2020 Feb 12, 2021	BUY	$13.47 - $24.89 $432,400 - $798,993	32,101 New	32,101 $741,000
Q3 2020 Nov 12, 2020	SELL	$12.89 - $15.89 $163,277 - $201,278	-12,667 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $112,229 - $198,745	12,667 New	12,667 $191,000
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $167,208 - $281,455	-25,220 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$7.48 - $10.75 $159,211 - $228,813	-21,285 Reduced 45.77%	25,220 $247,000
Q3 2019 Nov 14, 2019	BUY	$8.02 - $13.25 $372,970 - $616,191	46,505 New	46,505 $373,000
Q2 2018 Aug 10, 2018	SELL	$13.13 - $17.09 $1.75 Million - $2.28 Million	-133,594 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$13.76 - $17.12 $1.84 Million - $2.29 Million	133,594 New	133,594 $2.01 Million

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

314M

Call Options Held

630K

Put Options Held

669K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.83B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Amicus Therapeutics, Inc. Transaction History